C

얼라인드

238120KOSDAQ사진장비 및 광학기기 제조업

48.1 / 100

Reference Date: 2026-04-13

Financial Score17.5 / 40
News Sentiment15.6 / 25
Momentum5.0 / 20
Disclosure10.0 / 15
AI Analysis: PBR is significantly undervalued vs. peers but the high debt ratio poses financial risk. Declined 9.2% over the past month, and news sentiment is neutral.

Company InformationBased on 2025 Annual Report

Business Overview

Aligned is a technology venture company specializing in life science research and diagnostics, offering advanced products such as automated cell counting systems, tissue clearing and imaging systems, and digital cell imaging systems. Leveraging convergent technologies, the company has established a competitive edge globally with its X-CLARITY™ and CELENA® series, gaining trust from researchers. The growing life science tools market, driven by increased investment in healthcare and biotech, is expected to sustain the company's growth.

Number of Employees

66people

Average Salary

56.1M KRW

Score Calculation Basis

Detailed Financial Score

PER
19.88Industry Average 21.875.0Point

In line with industry avg

PBR
1.58Industry Average 2.805.5Point

Lower than industry avg (good)

ROE
8.01Industry Average -11.913.5Point

Well below industry avg

Debt Ratio
43.44Industry Average 18.090.0Point

2.4x industry avg (risky)

Trend 2023~20253.5 / 10 points
Revenue Growth Rate
1.0 / 3

Avg ▲2.6% (2-year basis)

Operating Profit Growth Rate
0.0 / 3

Avg ▼14.4% (2-year basis)

ROE Trend
2.5 / 4

Avg ROE 10.4% (declining, 3yr)

Detailed News Sentiment

2 totalPositive 1Neutral 0Negative 0Average Sentiment Score 75

Detailed Momentum

52-week position3.0Point

52w lower range (35%)

Current 4,095Won52-week high 6,05052-week low 3,020
1-month return1.0Point

1m -9.20% (falling)

Volume trend1.0Point

Volume decreasing

Detailed Disclosure

6 totalPositive 0Neutral 6Negative 0
  • Neutral본점소재지변경2026-03-31
  • Neutral정기주주총회결과2026-03-31
  • Neutral사업보고서 (2025.12)2026-03-23
  • Neutral감사보고서제출2026-03-19
  • Neutral주주총회소집공고2026-03-16